|
|
|
Volumn 21, Issue 4 SUPPL. 7, 1994, Pages 37-46
|
|
Salvage chemotherapy in recurrent or refractory squamous cell cancer of the uterine cervix
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMSACRINE;
CARBOPLATIN;
CHLORAMBUCIL;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DIAZIQUONE;
DOXORUBICIN;
EPIRUBICIN;
ESORUBICIN;
FLOXURIDINE;
FLUOROURACIL;
IFOSFAMIDE;
IPROPLATIN;
IRINOTECAN;
MAYTANSINE;
MELPHALAN;
METHOTREXATE;
MITOLACTOL;
MITOMYCIN;
PIPERAZINEDIONE;
PLATINUM DERIVATIVE;
SEMUSTINE;
TENIPOSIDE;
TRIAZINATE;
VINCRISTINE;
VINDESINE;
CANCER CHEMOTHERAPY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PALLIATIVE THERAPY;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
FEMALE;
HUMAN;
MULTIMODALITY CANCER THERAPY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT CANCER;
REVIEW;
SQUAMOUS CELL CARCINOMA;
UTERINE CERVIX CANCER;
ANTINEOPLASTIC AGENTS;
CARCINOMA, SQUAMOUS CELL;
CLINICAL TRIALS;
FEMALE;
HUMANS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
SALVAGE THERAPY;
UTERINE NEOPLASMS;
|
|
EID: 0027941394
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (9)
|
|
References (0)
|
